NCT00006812 Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer Status TERMINATED Phase PHASE2
NCT00006465 Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00006108 Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00006023 Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00005839 Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor Status COMPLETED Phase PHASE1
NCT00005649 Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00004187 Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00004183 Capecitabine in Treating Patients With Malignant Mesothelioma Status COMPLETED Phase PHASE2
NCT00004012 Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00003902 Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement Status COMPLETED Phase PHASE1/PHASE2
NCT00003867 Irinotecan and Capecitabine in Treating Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00003704 Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer Status COMPLETED Phase PHASE1